Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "Shionogi"

EMA Backs Ospemifene (Senshio) for Vulvar and Vaginal Atrophy

Ospemifene ( Senshio , Shionogi Limited) was recommended by a European Medicines Agency (EMA) panel for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy in postmenopausal women who are unable to use local vaginal estrogen ... American Journal of Public Health, 1 day ago
More November EMA/CHMP recommendations Pharma Letter, 22 hours ago

18 images for Shionogi

Bio Spectrum Asia, 5 days ago
DesignCurial, 2 weeks ago
Securities Technology Monitor, 1 week ago
Securities Technology Monitor, 3 weeks ago
Pharmafocus, 1 month ago
Pharma Letter, 1 month ago
DesignCurial, 1 month ago
DesignCurial, 1 month ago
DesignCurial, 1 month ago
DesignCurial, 1 month ago

SHIONOGI reports lower H1 net income, provides annual outlook

SHIONOGI & CO., LTD., a manufacturer of pharmaceuticals, has reported that net income for the first six months ended September 30, 2014 was JPY9.71 billion, or JPY28.98 per diluted share, compared to JPY21.09 billion, or JPY62.93 per diluted share, ...
 Individual.com1 week ago Shionogi revises H1 guidance  Individual.com4 weeks ago

Despite Label, Ospemifene Eases Multiple Menopause Symptoms

WASHINGTON, DC — Ospemifene ( Osphena , Shionogi) appears to improve multiple menopause-related vulvar and vaginal symptoms, even though its indication is only for moderate to severe dyspareunia, according to an analysis of data from two pivotal ...
 Diabetes Care2 weeks ago

Shionogi Pharma Talks R&D Collaboration Webinar now online

The UK Trade & Investment Japan webinar Shionogi Pharma Talks R&D Collaboration is now available
 Connect3 weeks ago Shionogi announces results from bacterial infection preclinical studies  Individual.com1 month ago C & O Pharmaceutical launches Rabeprazole Sodium for Injection in China  Individual.com1 month ago SHIONOGI : C&O Launches the First Rabeprazole Sodium for Injection (???®) in China  4 Traders1 month ago
Pharma Letter

MedImmune and Shionogi enter into license agreement for ACS biologic program

MedImmune, a biologics R&D arm of AstraZeneca, and Shionogi & Co., Ltd., a drug discovery-based pharmaceutical company, have entered into a license agreement under which MedImmune will in-license Shionogi's novel preclinical biologic program for the ...
 Individual.com1 month ago MedImmune in-licenses Shionogi biologic program in ACS  Drug Discovery News1 month ago MedImmune and Shionogi sign license agreement for Shionogi's preclinical biologics in acute coronary syndrome  Pharma Letter1 month ago AZ licenses ACS programme from old partner Shionogi  Big News Network1 month ago
[x]  
Securities Technology Monitor

Pfizer : National Association of Professional Women Announces Bonnie Kiefer, District Manager at Shionogi, Inc., a 2014 Professional Woman of the Year

NAPW honors Bonnie Kiefer , District Manager at Shionogi, Inc. , as a 2014 Professional Woman of the Year. She is recognized with this prestigious distinction for leadership in management. As the largest networking organization of professional women ...
 4 Traders1 week ago National Association of Professional Women Announces Bonnie Kiefer, District Manager at Shionogi, Inc., a 2014 Professional Woman of the Year  Individual.com1 week ago
[x]  
Securities Technology Monitor

Shionogi Inc. To Implement Cegedim Relationship Management CRM, Integrated Analytics, and Territory Alignment Solution to Increase Commercial Efficiency and Drive Costs Down

 Securities Technology Monitor3 weeks ago
[x]  

Shionogi Inc. Announces Four Abstracts To Be Presented At The 25th Annual Meeting Of The North American Menopause Society (NAMS) In Washington, DC

FLORHAM PARK, N.J. , Oct. 1, 2014 /PRNewswire/ -- Shionogi Inc., a global leader dedicated to women's health, will unveil four abstracts containing new analyses and safety and efficacy data from clinical trials of ospemifene (available in the U.S.
 Franklin Credit Management Corporation1 month ago Shionogi, Inc. Announces Four Abstracts To Be Presented At The In Washington, DC  BioSpace1 month ago
[x]  

SHIONOGI : Filing of Written Opposition to the Tax Reassessment Notice Received from the Osaka Regional Taxation Bureau

Filing of Written Opposition to the Tax Reassessment Notice Received from the Osaka Regional Taxation Bureau Osaka, Japan, November 11, 2014 - Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi" ...
 4 Traders1 week ago SHIONOGI : Notice of Revisions to Earnings Forecasts  4 Traders1 month ago Notice of Revisions to Earnings Forecasts  Noodls1 month ago

Shionogi Partnering 2009-2014

Naperville, IL -- (SBWIRE) -- 11/05/2014 -- Reportstack, provider of premium market research reports announces the addition of market report to
 A.M. Best2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less